Marina Chiara Garassino to Drug Approval
This is a "connection" page, showing publications Marina Chiara Garassino has written about Drug Approval.
Connection Strength
0.164
-
Position of a panel of international lung cancer experts on the approval decision for use of durvalumab in stage III non-small-cell lung cancer (NSCLC) by the Committee for Medicinal Products for Human Use (CHMP). Ann Oncol. 2019 02 01; 30(2):161-165.
Score: 0.164